IDH1 (AG 120) Inhibitor in Patients With IDH1 Mutated Myelodysplastic Syndrome
Clinical trial NCT03503409 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03503409
- Sponsor
- Groupe Francophone des Myelodysplasies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-14
- Primary completion
- 2027-04-02
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.